Hellweg's Insolvency Ends a Long Overhang as W.P. Carey Raises Guidance — but the Tape Stays Skeptical

Q2 resolves the lingering German tenant problem, leans into a CPI tailwind, and confronts a fresh generic-drug tariff question — yet the stock drew down ~7% from its pre-earnings high.

WPC · Earnings Call · 2026-07-29

Hellweg's Insolvency: The Overhang Reaches Its Endgame

The defining development in W.P. Carey's second-quarter report isn't a new headline so much as the resolution of an old one. German DIY retailer Hellweg — a tenant that has anchored the credit watch list for years — filed for insolvency, and management framed the filing as an accelerant rather than a fresh wound. Exposure has been cut from 35 stores to 16, and gross rent from Hellweg is now just 90 basis points of ABR, no longer a top-20 tenant.

Hellweg's recent insolvency filing may help accelerate the process of taking back the remaining stores and bringing the situation to a close.
Jason Fox, CEO · 2026-07-29

Fox added that springing leases are already in place on half the stores at rents comparable to what Hellweg was paying, with the remainder expected to be lined up with tenant or buyer agreements by year-end. The CFO quantified the damage: a net ~$3 million rent loss in 2026, with total portfolio rent-loss guidance lowered to $7–10 million. “The bottom line is that Hellweg has a negligible impact on our 2026 earnings outlook.” — ToniAnn Sanzone, CFO · 2026-07-29 The contrast with prior quarters is stark. On the April call, Brooks Gordon described Hellweg as "about 1% by ABR—and coming down quite quickly," targeting removal from the top 25 by midyear. “We are on track to have that out of our top 25 around midyear.” — Brooks G. Gordon · 2026-04-29 That target has now been hit, and the insolvency process keyword jumped to a momentum of 179 this quarter — a sign the market is finally tagging WPC's resolution story.

Inflation Tailwind Meets a Skeptical Tape

The second pillar is the CPI-linked increases flowing through the portfolio. With 49% of same-store leases tied to CPI and most European leases indexed, management argues higher energy prices will increasingly lift rents. CFO Toni Sanzone reported that international CPI expectations have risen roughly 100 basis points since the start of the year: “Since the start of the year, we've seen the international CPI increase about 100 basis points from our initial projections.” — ToniAnn Sanzone, CFO · 2026-07-29 But here's the tension: the broader market's energy tape isn't confirming the inflation thesis. Over the last 90 days, the global tape shows "barrel of oil" among the steepest decliners (−14.6%), and "Middle East disruption" has faded even as headlines persist. W.P. Carey is leaning into an energy-inflation narrative that commodities are currently discounting — a divergence worth watching as the Q2 CPI settlements land. The stock's post-earnings drift suggests the market shares some skepticism. Shares notched a 90-day high of $76.69 on July 24, just before the report, and have since drawn down about 7%. Fox addressed this head-on in closing remarks:

We don't believe the recent stock performance relative to peers is fully reflecting how well we've executed.
Jason Fox, CEO · 2026-07-29

Guidance Raises Keep Stacking

The operational record, at least, is unambiguous. Full-year AFFO per share guidance was raised to $5.19–$5.27, implying roughly 5.2% growth, and investment deal volume guidance was lifted to $1.7–$2.1 billion. Year-to-date investments closed at $1.3 billion at a 7.4% initial cap rate, including the $400 million sale-leaseback with GardenCore, now the fourth-largest tenant. The underlying cash flow supports the message: Funds From Operations reached $219M in Q1 2026, up 26% year-over-year and 12% sequentially, before the second-quarter deployment even fully ramps.

New Risk On the Horizon: Generic Drug Tariffs

Fresh this quarter is the generic drug tariff angle on Apotex, W.P. Carey's second-largest tenant, which surfaced when an analyst pressed on U.S. tariff threats. Fox's answer leaned on asset criticality and credit improvement: “They are also infill Toronto, which is one of the better industrial markets in North America,” — Jason Fox, CEO · 2026-07-29 noting Apotex has since gone public with a ~$6 billion equity market cap. Whether tariffs materialize is speculation, but this is a company-specific wrinkle inside the broader tariff narrative that dominated the 2026 macro tape.

Funding Runway into 2027

The quiet engine remains the balance sheet. Unsettled forward equity of $691 million, no remaining 2026 maturities, and $2.7 billion of liquidity give W.P. Carey runway to fund deals well into 2027. The prior quarter's framing of $650 million in forward equity — “we are sitting on $650 million of forward equity right now that is left to be settled” — Jason E. Fox · 2026-04-29 — has now grown alongside a 5.2% bond refinancing. Longer term, Lineage shares offer another potential source of equity beginning late 2027, a theme that has moved from theoretical to a stated capital-plan option. The bottom line: W.P. Carey has turned a multi-year rent loss overhang into a guided-up year, with CPI flow-through and a fortress balance sheet as the growth engines. The lingering question is whether the market will pay up for it — the post-earnings drawdown says not yet.